All lobbying filings

CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. filed a Q4 report for HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION on January 13, 2026, reporting $10,000 in lobbying income.

Lobbying for HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION · patient advocacy organization for individuals suffering from a rare disease

All filings by CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. · Everything HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 13, 2026

Income

$10,000

What the client paid this registrant for the period.

Client based in

Maryland

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Defense

Hereditary Hemorrhagic Telanglectasia (HHT)

Health Issues

HR 4016/S 2572, FY26 Defense Appropriations Act, Peer Reviewed Medical Research Program designation for Hereditary Hemorrhagic Telangiectasia (HHT); HR 5304/S 2587, FY26 Labor HHS Education Appropriations Act, National HHT Center of Excellence Program

Bills named in this filing 2

H.R. 4016
Department of Defense Appropriations Act, 2026
H.R. 5304
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.